Table 2.
Components of PLASMIC and Bentley score of the enrolled patients.
| Patient Number | FFP/CP ratio |
Platelet count (×109/L) | Indirect bilirubin (μmol/L) |
Uncorrected reticulocyte (%) | Active cancer | MCV (fL) | INR | Creatinine (μmol/L) |
D-dimer (μg/ml) |
PLASMIC score |
Bentley score |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 0.61 | 8 | 22.7 | 21.63 | NO | 108.6 | 1.04 | 89 | 2.52 | 6 | 21 |
| 2 | 0.88 | 20 | 17.5 | 16.59 | NO | 101.1 | 1.05 | 62 | 2.1 | 6 | 21 |
| 3∗# | 1.86 | 6 | 65.1 | 22.29 | NO | 108 | 1.02 | 68 | 3.12 | 6 | 41.5 |
| 4 | 0.73 | 29 | 16.7 | 18.72 | NO | 94.4 | 1.13 | 64.3 | 1.65 | 6 | 21 |
| 5 | 0.93 | 9 | 23.5 | 14.83 | NO | 86.2 | 1.2 | 84 | 1.18 | 7 | 21 |
| 6# | 1.48 | 28 | 16.1 | 16.39 | NO | 109.3 | 1.01 | 67 | 2.13 | 6 | 21 |
| 7 | 0.85 | 6 | 28.1 | 19.74 | NO | 104 | 1.1 | 66 | 2.09 | 6 | 41.5 |
| 8∗ | 0.72 | 16 | 12.2 | 10 | NO | 95 | 1.04 | 39 | 0.65 | 6 | 21 |
| 9 | 1.14 | 12 | 80.4 | 16.73 | NO | 107.3 | 0.73 | 101 | 2.22 | 6 | 41.5 |
| 10 | 1.11 | 16 | 23.3 | 20.21 | NO | 99 | 0.99 | 62 | 0.8 | 6 | 21 |
| 11 | 0.94 | 11 | 82.3 | 4.84 | Thyroid | 71.7 | 1.18 | 178 | 6.21 | 5 | 20 |
| 12 | 1.40 | 18 | 18.6 | 9.76 | NO | 96.5 | 0.81 | 81 | 1.47 | 6 | 21 |
| 13∗ | 1.81 | 6 | 73 | 6.55 | NO | 84.1 | 0.98 | 86 | 1.84 | 7 | 41.5 |
| 14 | 0.56 | 6 | 49.7 | 19.32 | NO | 108.8 | 0.97 | 66.8 | 2.42 | 6 | 41.5 |
| 15 | 1.21 | 13 | 31.5 | 13.48 | NO | 100.6 | 0.98 | 68.4 | 3.76 | 6 | 41.5 |
| 16 | 0.73 | 21 | 17.5 | 4.83 | NO | 76.3 | 0.92 | 79 | 1.35 | 7 | 21 |
| 17 | 3.45 | 11 | 19.5 | 19.47 | NO | 86.4 | 0.72 | 108 | 2.97 | 7 | 21 |
| 18# | 1.12 | 18 | 17 | 4.22 | esophagus | 88.3 | 0.86 | 67 | 0.99 | 6 | 21 |
| 19 | 1.08 | 11 | 62 | 4.71 | NO | 87.2 | 1.03 | 92 | 1.08 | 7 | 41.5 |
| 20 | 1.28 | 10 | 38.4 | 8.94 | NO | 102.2 | 1.11 | 52 | 0.66 | 6 | 41.5 |
| 21 | 1.25 | 13 | 16.7 | 16.8 | NO | 106 | 1.09 | 74 | 0.89 | 6 | 21 |
| 22 | 1.17 | 24 | 36.6 | 7.42 | NO | 89.4 | 1.17 | 95 | 3.61 | 7 | 41.5 |
| 23∗ | 1.28 | 21 | 12.3 | 11.32 | NO | 92.5 | 1.04 | 104 | 1.07 | 6 | 21 |
| 24 | 1.17 | 19 | 8.9 | 3.4 | NO | 85.2 | 0.92 | 40 | 0.5 | 7 | 21 |
| 25 | 0.87 | 11 | 43.3 | 17.22 | NO | 90.4 | 1.07 | 85.8 | 1.68 | 6 | 41.5 |
| 26∗ | 1.16 | 8 | 27.2 | 19.43 | NO | 90 | 1.09 | 60 | 8.22 | 6 | 31.5 |
| 27 | 0.89 | 22 | 8.3 | 9.42 | NO | 97.3 | 1.05 | 142 | 2.01 | 6 | 21 |
MCV: mean corpuscular volume; INR: international normalized ratio; ∗: patients who were evaluated for ADAMTS13 activity; #: patients who did not achieve complete remission before therapeutic plasma exchange ceased.